News Daily News ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics Caitlin E. Cox August 03, 2011
News Daily News Meta-analysis Finds Equivalence Between First-, Second-Generation DES L.A. McKeown August 02, 2011
News Industry News Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent July 26, 2011
News Daily News ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute Jason Kahn July 21, 2011
News Daily News DES Show Advantage over BMS for Heart Transplant Complication L.A. McKeown July 01, 2011
News Industry News Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents June 26, 2011
News Daily News Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness Caitlin E. Cox June 24, 2011
News Daily News Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development L.A. McKeown June 15, 2011
News Industry News Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent June 15, 2011
News Conference News Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years Caitlin E. Cox May 20, 2011
News Conference News Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES Jason Kahn May 19, 2011
News Industry News Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years May 19, 2011
News Daily News Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year Leah Lawrence April 26, 2011
News Conference News Therapies Take on In-Stent Restenosis with Mixed Results Caitlin E. Cox April 15, 2011
News Daily News Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis L.A. McKeown April 15, 2011
News Conference News ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details Caitlin E. Cox April 08, 2011
News Conference News PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease April 05, 2011
News Conference News EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES Caitlin E. Cox April 05, 2011